人工智能驱动的生物标志物发现:提高癌症诊断和预后的精度
1Department of Research and Publications, Kampala International University, P. O. Box 20000, Kampala, Uganda. esther.alum@kiu.ac.ug.
Discover oncology
|March 14, 2025
概括
人工智能 (AI) 通过发现新生物标志物来改善早期检测和向治疗,从而提高癌症护理. 在瘤学中,人工智能解决了数据质量和伦理等挑战,以获得更好的患者结果.
科学领域:
- 瘤学和医疗信息学
- 生物标志物发现和精准医学
背景情况:
- 癌症是一个主要的全球健康挑战,每年造成数百万人的死亡,与人口统计,社会经济和生活方式因素相关的发病率上升.
- 许多国家的查设施有限,阻碍了早期癌症检测和预防工作.
- 人工智能 (AI) 为癌症诊断,预后和治疗提供了一种变革性的方法.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


